Pandemics have killed at least a half billion people over the past two millennia. Today a new plague, COVID-19, is stalking humanity. But in the age of biotechnology, humanity is no longer defenseless. Biotechnology in the Time of COVID-19 is a collection of stories about the biotechnology industry—its purpose, its people and how it has risen to battle the COVID-19 virus—told by forty-seven leaders of that industry in their own words.
The industry is an ecosystem of scientists, doctors, patients, entrepreneurs, investors, bankers, analysts and reporters, all committed to treating and curing disease. It has been built over the past forty years, producing medical advances at an electrifying rate. As the COVID-19 pandemic emerged, within just two months hundreds of companies had pivoted to apply their technologies to combat the virus.
The contributors to this book offer inside views of this seminal industry, historical and personal perspectives, lessons learned, and looks into the future. Diverse as these leaders are, they are united by their conviction that science and medicine will light humanity’s way to greater health and longevity than it has ever known.
The editor royalties and a portion of publisher revenues will be donated to two nonprofits focused on rare disease research: Global Genes (globalgenes.org) and The Institute for Life Changing Medicines (lifechangingmedicines.org).